PubMed چکیده/رکورد

Mapping country-level structural capacity constraints in brachytherapy infrastructure for locally advanced cervical cancer in the Americas: a cross-sectional study.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

OBJECTIVE: To develop a reproducible public-data method for mapping country-level capacity constraints in brachytherapy infrastructure relevant to guideline-concordant treatment for locally advanced cervical cancer across the Americas, comparing expected disease-stage-specific need with reported brachytherapy unit counts. METHODS: We performed a cross-sectional ecological study at the country/territory level. Incident cervical cancer cases among females in 2022 were taken from GLOBOCAN-derived extracts and were linked with radiotherapy infrastructure data from the International Atomic Energy Agency DIrectory of RAdiotherapy Centres for countries in the Americas. Expected locally advanced cervical cancer cases were estimated as 37.0% of incident cervical cancer cases; 25.8% and 52.1% were used as low-high sensitivity bounds. The primary metric was expected locally advanced cervical cancer cases per DIrectory of RAdiotherapy Centres-reported brachytherapy unit. Countries or territories with zero reported units, no DIrectory of RAdiotherapy Centres data available, or unavailable cancer burden data were classified separately. Countries with at least 1 unit and available burden data were grouped into quartiles of estimated capacity constraints. RESULTS: The combined public-data register contained 37 unique countries/territories in the Americas region: 34 with cervical cancer burden data and 33 with DIrectory of RAdiotherapy Centres infrastructure information. Thirty countries/territories had both burden and infrastructure data; 29 had at least 1 reported brachytherapy unit. In the primary linked set, there were 77,764 incident cervical cancer cases, 28,773 expected locally advanced cervical cancer cases, and 1060 reported brachytherapy units. Among countries/territories with at least 1 unit, the median number of expected locally advanced cervical cancer cases per unit was 59.6 (interquartile range; 30.0-112.8) for 2022 data. The highest measurable capacity constraints occurred in Honduras (169.5), Paraguay (137.5), Nicaragua (133.4), Ecuador (132.6), and Guatemala (130.3). Central America had the highest regional capacity constraints (116.8), followed by South America (61.2), the Caribbean (53.0), and North America (12.7). CONCLUSIONS: Public-data analysis can identify plausible structural infrastructure capacity-constraint signals relevant to cervical cancer management in the Americas. The metric should be interpreted as indicating hypothesis-generating potential infrastructure capacity constraints, not patient-level treatment receipt, treatment quality, or operational capacity. The next phase should validate DIrectory of RAdiotherapy Centres data, geocode centers, model travel time, and link to patient-level treatment and outcome data where feasible to improve the capacity analysis.

متن کامل اصلی

متن در JumpToDate ذخیره نشده است.

برای بررسی دسترسی کتابخانه‌ای یا خرید، رکورد اصلی را باز کنید.

رفتن به منبع اصلی

کلیدواژه‌ها

AmericasBrachytherapy;Health ResourcesRadiotherapyUterine Cervical Neoplasms
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

Role of Radiotherapy After Breast-Conserving Surgery in T1-2N0M0 Luminal (HR+/HER2-) Breast Cancer Stratified by Tumor Quadrant Location.

BACKGROUND The survival association of adjuvant radiotherapy (RT) in early-stage node-negative luminal (HR+/HER2-) breast cancer remains under evaluation, and whether this association is modified by tumor quadrant location is unknown. MATERIAL AND METHODS We identified 5831 patients with T1-2N0M0 luminal breast cancer treated with breast-conserving surgery from the Surveillance, Epidemiology, and End Results (SEER) database (2010-2017)…

PubMed2026

Atypical presentations of Lhermitte's sign after treatment for human papillomavirus-associated oropharyngeal squamous cell carcinoma.

Lhermitte's sign (LS) is characterised by a brief electric shock-like sensation elicited by neck flexion that radiates down the spine and may extend into the posterior aspects of the legs. It is a clinical indicator of cervical or upper thoracic dorsal column dysfunction, most commonly due to demyelination or intrinsic spinal cord pathology. It may occur after head and neck (chemo)radiotherapy. We describe two patients with human papil…

PubMed2026

Patient-reported swallowing burden and FEES findings in disease-free oropharyngeal cancer survivors after chemoradiotherapy.

PURPOSE: Oropharyngeal dysphagia is a frequent long-term sequela in survivors of oropharyngeal cancer treated with chemoradiotherapy (CRT), with significant impact on quality of life (QoL). Flexible endoscopic evaluation of swallowing (FEES) provides objective information on swallowing physiology, whereas patient-reported outcome measures (PROMs) capture perceived dysphagia burden. This study explored how FEES findings and PROMs provid…

PubMed2026

Volumetric analysis of radiographic changes after stereotactic radiosurgery for treatment of non-responding brain metastases.

PURPOSE: Stereotactic radiosurgery (SRS) effectively treats brain metastases, yet some lesions ultimately require post-SRS surgery due to local failure. We examined whether the use of volumetric changes in FLAIR hyperintensity and/or necrosis in conjunction with enhancing volumetric changes after Gamma Knife SRS correlate with pathological outcome at subsequent surgery. METHODS: We queried our institutional database for patients who re…